The expression characteristics and clinical significance of ACP6, a potential target of nitidine chloride, in hepatocellular carcinoma.

Abstract

BACKGROUND:

Acid phosphatase type 6 (ACP6) is a mitochondrial lipid phosphate phosphatase that played a role in regulating lipid metabolism and there is still blank in the clinico-pathological significance and functional roles of ACP6 in human cancers. No investigations have been conducted on ACP6 in hepatocellular carcinoma (HCC) up to date.

METHODS:

Herein, we appraised the clinico-pathological significance of ACP6 in HCC via organizing expression profiles from globally multi-center microarrays and RNA-seq datasets. The molecular basis of ACP6 in HCC was explored through multidimensional analysis. We also carried out in vitro and in vivo experiment on nude mice to investigate the effect of knocking down ACP6 expression on biological functions of HCC cells, and to evaluate the expression variance of ACP6 in xenograft of HCC tissues before and after the treatment of NC.

RESULTS:

ACP6 displayed significant overexpression in HCC samples (standard mean difference (SMD) = 0.69, 95% confidence interval (CI) = 0.56-0.83) and up-regulated ACP6 performed well in screening HCC samples from non-cancer liver samples. ACP6 expression was also remarkably correlated with clinical progression and worse overall survival of HCC patients. There were close links between ACP6 expression and immune cells including B cells, CD8 + T cells and naive CD4 + T cells. Co-expressed genes of ACP6 mainly participated in pathways including cytokine-cytokine receptor interaction, glucocorticoid receptor pathway and NABA proteoglycans. The proliferation and migration rate of HCC cells transfected with ACP6 siRNA was significantly suppressed compared with those transfected with negative control siRNA. ACP6 expression was significantly inhibited by nitidine chloride (NC) in xenograft HCC tissues.

CONCLUSIONS:

ACP6 expression may serve as novel clinical biomarker indicating the clinical development of HCC and ACP6 might be potential target of anti-cancer effect by NC in HCC.

• Authors: Li Gao, Dan-Dan Xiong, Xia Yang, Jian-Di Li, Rong-Quan He, Zhi-Guang Huang, Ze-Feng Lai, Li-Min Liu, Jia-Yuan Luo, Xiu-Fang Du, Jiang-Hui Zeng, Ming-Fen Li, Sheng-Hua Li, Yi-Wu Dang, Gang Chen
• Journal: BMC cancer (BMC Cancer) Vol. 22 Issue 1 Pg. 1244 (Dec 01 2022) ISSN: 1471-2407 [Electronic] England
• PMID: 36456931 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s).

Chemical References

• Acid Phosphatase
• nitidine
• RNA, Small Interfering
• ACP6 protein, human

Topics

• Animals
• Humans
• Mice
• Acid Phosphatase (genetics)
• Carcinoma, Hepatocellular (drug therapy, genetics)
• Liver Neoplasms (drug therapy, genetics)
• Mice, Nude
• RNA, Small Interfering